Differential effects of quercetin, apigenin and genistein on signalling pathways of protease-activated receptors PAR1 and PAR4 in platelets

被引:39
作者
Navarro-Nunez, L. [1 ]
Rivera, J. [1 ]
Guerrero, J. A. [1 ]
Martinez, C. [1 ]
Vicente, V. [1 ]
Lozano, M. L. [1 ]
机构
[1] Univ Murcia, Unit Haematol & Med Oncol, Ctr Reg Hemodonac, Murcia 30003, Spain
关键词
flavonoids; thrombin; protease-activated receptors; platelets; TYROSINE KINASE INHIBITOR; THROMBOXANE A(2); P2Y(12) RECEPTOR; FLAVONOIDS INHIBIT; CA2+ MOBILIZATION; GAMMA-THROMBIN; HEART-DISEASE; CALDAG-GEFI; AGGREGATION; SECRETION;
D O I
10.1111/j.1476-5381.2009.00440.x
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Background and purpose: The modulation by flavonoids of platelet responses induced by thrombin has been little investigated, and the antiplatelet activity, as well as possible inhibitory mechanisms of these compounds on thrombin signalling, has not yet been elucidated. We explored whether flavonoids affect platelet signalling pathways triggered by thrombin and by the selective activation of its protease-activated receptors (PARs) 1 and 4, and analysed the antagonism of these polyphenols at thrombin receptors. Experimental approach: We investigated the effect of a range of polyphenolic compounds on platelet aggregation, 5-HT secretion, intracellular calcium mobilization, protein kinase activity and tyrosine phosphorylation, triggered by thrombin and PAR agonist peptides (PAR-APs). The ability of these flavonoids to bind to thrombin receptors was investigated by competitive radioligand binding assays using 125I-thrombin. Key results: Quercetin, apigenin and genistein impaired platelet aggregation, as well as 5-HT release and calcium mobilization, induced by thrombin and PAR-APs. Quercetin and apigenin were inhibitors of protein kinases, but genistein exhibited a minimal ability to suppress platelet phosphorylation. Binding assays did not establish any kind of interaction between thrombin receptors and any of the flavonoids tested. Conclusions and implications: Quercetin, apigenin and genistein did not inhibit thrombin responses by interacting with thrombin receptors, but by interfering with intracellular signalling. While inhibition by genistein may be a consequence of affecting calcium mobilization, subsequent platelet secretion and aggregation, for quercetin and apigenin, inhibition of kinase activation may also be involved in the impairment of platelet responses.
引用
收藏
页码:1548 / 1556
页数:9
相关论文
共 50 条
[41]   Two types of protease-activated receptors (PAR-1 and PAR-2) mediate calcium signaling in rat retinal ganglion cells RGC-5 [J].
Luo, WB ;
Wang, YF ;
Reiser, G .
BRAIN RESEARCH, 2005, 1047 (02) :159-167
[42]   Regulation of postaggregation events induced by protease-activated receptor 1 ligation in human platelets: Evidence of differential signaling pathways [J].
Ramars, ASS ;
Mukhopadhyay, S ;
Dash, D .
ARCHIVES OF BIOCHEMISTRY AND BIOPHYSICS, 2002, 398 (02) :253-260
[43]   Differential expression of protease activated receptor 1 (Par1) and pY397FAK in benign and malignant human ovarian tissue samples [J].
Grisaru-Granovsky, S ;
Salah, Z ;
Maoz, M ;
Pruss, D ;
Beller, U ;
Bar-Shavit, R .
INTERNATIONAL JOURNAL OF CANCER, 2005, 113 (03) :372-378
[44]   Protease-activated receptors (PAR)-1 and-3 drive epithelial-mesenchymal transition of alveolar epithelial cells - potential role in lung fibrosis [J].
Wygrecka, Malgorzata ;
Didiasova, Miroslava ;
Berscheid, Sebastian ;
Piskulak, Katarzyna ;
Taborski, Brigitte ;
Zakrzewicz, Dariusz ;
Kwapiszewska, Grazyna ;
Preissner, Klaus T. ;
Markart, Philipp .
THROMBOSIS AND HAEMOSTASIS, 2013, 110 (02) :295-307
[45]   Effect of protease-activated receptor (PAR)-1, -2 and -4-activating peptides, thrombin and trypsin in rat isolated airways [J].
Chow, JM ;
Moffatt, JD ;
Cocks, TM .
BRITISH JOURNAL OF PHARMACOLOGY, 2000, 131 (08) :1584-1591
[46]   Protease-activated receptor 1 (PAR1) coupling to Gq/11 but not to Gi/o or G12/13 is mediated by discrete amino acids within the receptor second intracellular loop [J].
McCoy, Kelly L. ;
Gyoneva, Stetka ;
Vellano, Christopher P. ;
Smrcka, Alan V. ;
Traynelis, Stephen F. ;
Hepler, John R. .
CELLULAR SIGNALLING, 2012, 24 (06) :1351-1360
[47]   Protease-activated receptor-1-mediated DNA synthesis in cardiac fibroblast is via epidermal growth factor receptor transactivation - Distinct PAR-1 signaling pathways in cardiac fibroblasts and cardiomyocytes [J].
Sabri, A ;
Short, J ;
Guo, JF ;
Steinberg, SF .
CIRCULATION RESEARCH, 2002, 91 (06) :532-539
[48]   Co-existence of two types of [Ca2+]i-inducing protease-activated receptors (PAR-1 and PAR-2) in rat astrocytes and C6 glioma cells [J].
Ubl, JJ ;
Vöhringer, C ;
Reiser, G .
NEUROSCIENCE, 1998, 86 (02) :597-609
[49]   The in-vitro effects of E5555, a protease-activated receptor (PAR)-1 antagonist, on platelet biomarkers in healthy volunteers and patients with coronary artery disease [J].
Serebruany, Victor L. ;
Kogushi, Motoji ;
Dastros-Pitei, Daniela ;
Flather, Marcus ;
Bhatt, Deepak L. .
THROMBOSIS AND HAEMOSTASIS, 2009, 102 (01) :111-119
[50]   Discovery of 2,3-Dihydro[1,4]dioxino[2,3-g]benzofuran Derivatives as Protease Activated Receptor 4 (PAR4) Antagonists with Potent Antiplatelet Aggregation Activity and Low Bleeding Tendency [J].
Chen, Panpan ;
Chen, Cai ;
Zheng, Yizheng ;
Chen, Fangjun ;
Liu, Zhaojun ;
Ren, Shenhong ;
Song, Hangyu ;
Liu, Tongdan ;
Lu, Zhipeng ;
Sun, Hongbin ;
Kong, Yi ;
Yuan, Haoliang .
JOURNAL OF MEDICINAL CHEMISTRY, 2024, 67 (07) :5502-5537